Oncodesign Precision Medicine
ALOPM.PA
#9834
Rank
C$22.91 M
Marketcap
$1.15
Share price
-13.48%
Change (1 day)
-57.09%
Change (1 year)

Revenue for Oncodesign Precision Medicine (ALOPM.PA)

Revenue in 2023: C$1.7 Million

According to Oncodesign Precision Medicine's latest financial reports the company's current revenue (TTM ) is C$1.7 Million. In 2023 the company made a revenue of C$1.7 Million a decrease over the revenue in the year 2022 that were of C$12.3 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Oncodesign Precision Medicine from 2020 to 2023

Annual revenue

Year Revenue Change
2023C$1.7 M-86.16%
2022C$12.3 M97.32%
2021C$6.23 M-20.02%
2020C$7.79 M